TY  - GEN
AU  - Chougnet,Cecile N
AU  - Borget,Isabelle
AU  - Leboulleux,Sophie
AU  - de la Fouchardiere,Christelle
AU  - Bonichon,Françoise
AU  - Criniere,Lise
AU  - Niccoli,Patricia
AU  - Bardet,Stéphane
AU  - Schneegans,Olivier
AU  - Zanetta,Sylvie
AU  - Schvartz,Claire
AU  - Drui,Delphine
AU  - Chauffert,Bruno
AU  - Rohmer,Vincent
AU  - Schlumberger,Martin
TI  - Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort
SN  - 1557-9077
PY  - 2016///0104
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carcinoma, Neuroendocrine
KW  - drug therapy
KW  - Child
KW  - Female
KW  - France
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Piperidines
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Thyroid Neoplasms
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1089/thy.2014.0361
ER  -